Differential Impact of Relative Dose-Intensity Reductions in Diffuse Large B-Cell Lymphoma Treated with R-CHOP21 or R-CHOP14

DLBCL is an aggressive lymphoma treated with R-CHOP. Recently, attempts have been made to improve the outcome by increasing both dose-density and intensity but there have been no benefits in terms of survival. When treating malignancies RDI is important to consider but there is little published info...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:PLoS One
Autori principali: Gutiérrez, Antonio, Bento, Leyre, Bautista-Gili, Antonia Maria, Garcia, Francesc, Martinez-Serra, Jordi, Sanchez, Blanca, Martorell, Clara, Gines, Jordi, Garcia, Lucia, Gimeno, Eva, Ferraro, Mariana, Del Campo, Raquel, Bargay, Joan, Perez, Albert, Vercher, Javier, Scaff, Miguel, Pacheco, Ana, Ballester, Carmen, Garcia, Florencia, Ramos, Rafael, Salar, Antonio, Besalduch, Joan
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2015
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4409365/
https://ncbi.nlm.nih.gov/pubmed/25909361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0123978
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi